These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38253589)

  • 1. Programmable RNA base editing with photoactivatable CRISPR-Cas13.
    Yu J; Shin J; Yu J; Kim J; Yu D; Heo WD
    Nat Commun; 2024 Jan; 15(1):673. PubMed ID: 38253589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of CRISPR/Cas13-Based RNA Editing in Plants.
    Kavuri NR; Ramasamy M; Qi Y; Mandadi K
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Method for Programmable RNA Editing Using CRISPR Effector Cas13X.1.
    Li L; Liu W; Zhang H; Cai Q; Wen D; Du J; Sun J; Li L; Gao C; Lin P; Wu M; Jiang J
    Tohoku J Exp Med; 2023 May; 260(1):51-61. PubMed ID: 36823185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications.
    Tang T; Han Y; Wang Y; Huang H; Qian P
    Front Cell Dev Biol; 2021; 9():677587. PubMed ID: 34386490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Engineered CRISPR-Cas-Mediated Systems for Site-Specific RNA Editing.
    Marina RJ; Brannan KW; Dong KD; Yee BA; Yeo GW
    Cell Rep; 2020 Nov; 33(5):108350. PubMed ID: 33147453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family.
    Liu L; Pei DS
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing PspCas13b-based enhanced RESCUE system, eRESCUE, with efficient RNA base editing.
    Li G; Wang Y; Li X; Wang Y; Huang X; Gao J; Hu X
    Cell Commun Signal; 2021 Aug; 19(1):84. PubMed ID: 34380502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicing.
    Fiflis DN; Rey NA; Venugopal-Lavanya H; Sewell B; Mitchell-Dick A; Clements KN; Milo S; Benkert AR; Rosales A; Fergione S; Asokan A
    Nat Commun; 2024 Mar; 15(1):2325. PubMed ID: 38485709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of the versatile CRISPR-Cas13 RNA targeting system.
    Kordyś M; Sen R; Warkocki Z
    Wiley Interdiscip Rev RNA; 2022 May; 13(3):e1694. PubMed ID: 34553495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible RNA targeting and N6-methyladenosine editing by a split-Cas13 architecture.
    Li Y; Sun Q; Yang Z; Yuan G
    J Mol Cell Biol; 2024 Jul; 16(1):. PubMed ID: 38216515
    [No Abstract]   [Full Text] [Related]  

  • 11. The double life of CRISPR-Cas13.
    Bot JF; van der Oost J; Geijsen N
    Curr Opin Biotechnol; 2022 Dec; 78():102789. PubMed ID: 36115160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells.
    Lin P; Qin S; Pu Q; Wang Z; Wu Q; Gao P; Schettler J; Guo K; Li R; Li G; Huang C; Wei Y; Gao GF; Jiang J; Wu M
    Mol Cell; 2020 Jun; 78(5):850-861.e5. PubMed ID: 32348779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alleviation of neurological disease by RNA editing.
    Zhang S; Chen L; Zhang Y; Fang D
    Methods; 2021 Oct; 194():94-99. PubMed ID: 33933604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmable RNA targeting with CRISPR-Cas13.
    Shi P; Wu X
    RNA Biol; 2024 Jan; 21(1):1-9. PubMed ID: 38764173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA editing with CRISPR-Cas13.
    Cox DBT; Gootenberg JS; Abudayyeh OO; Franklin B; Kellner MJ; Joung J; Zhang F
    Science; 2017 Nov; 358(6366):1019-1027. PubMed ID: 29070703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Basis and Promise of Programmable RNA Editing and Modification.
    Lo N; Xu X; Soares F; He HH
    Front Genet; 2022; 13():834413. PubMed ID: 35154288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cytosine deaminase for programmable single-base RNA editing.
    Abudayyeh OO; Gootenberg JS; Franklin B; Koob J; Kellner MJ; Ladha A; Joung J; Kirchgatterer P; Cox DBT; Zhang F
    Science; 2019 Jul; 365(6451):382-386. PubMed ID: 31296651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in CRISPR-Cas systems for RNA targeting, tracking and editing.
    Wang F; Wang L; Zou X; Duan S; Li Z; Deng Z; Luo J; Lee SY; Chen S
    Biotechnol Adv; 2019; 37(5):708-729. PubMed ID: 30926472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoactivatable RNA N
    Zhao J; Li B; Ma J; Jin W; Ma X
    Small; 2020 Jul; 16(30):e1907301. PubMed ID: 32583968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compact RNA editors with small Cas13 proteins.
    Kannan S; Altae-Tran H; Jin X; Madigan VJ; Oshiro R; Makarova KS; Koonin EV; Zhang F
    Nat Biotechnol; 2022 Feb; 40(2):194-197. PubMed ID: 34462587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.